HORIZON-JU-IHI-2024-07-03-singe-stage
HORIZON-JU-IHI-2024-07-03-singe-stage
Programme: Horizon Europe
4 projects · €41,854,075 total EU contribution (project-level) · 94 participating organizations · 23 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€41,854,075
Countries active
Participant organizations by country (headquarters in CORDIS).
- Italy (14)
- Germany (11)
- Netherlands (11)
- Spain (9)
- CH (8)
- SE (6)
- BE (5)
- UK (5)
- France (4)
- AT (3)
- DK (3)
- US (3)
- PT (2)
- EE (1)
- EL (1)
- FI (1)
- HU (1)
- IE (1)
- KR (1)
- LT (1)
- NO (1)
- PL (1)
- SI (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH2 projects · DE
- 3D-PHARMXCHANGE1 projects · NL
- Menarini Diagnostics1 projects · IT
- AAU1 projects · DK
- UNIVERSITAIR MEDISCH CENTRUM GRONINGEN1 projects · NL
- HEALTH PROTECTION AGENCYATS OF BRIANZA1 projects · IT
- AGES1 projects · AT
- ALTONA1 projects · DE
- AMSTERDAM UMC RESEARCH BV1 projects · NL
- AIMAC1 projects · IT
- ATRYS HEALTH1 projects · ES
- AZIENDA SOCIO-SANITARIA TERRITORIALE (ASST) SANTI PAOLO E CARLO1 projects · IT
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
IMAGING FOR PATIENT BENEFIT IN ARTHRITIS AutoPiX · 101194766 | HORIZON | €10,729,428 | €2,181,193 | Details |
Virus related biomarkers to improve management of chronic conditions VIROMARKERS · 101194735 | HORIZON | €2,329,504 | €448,125 | Details |
Biomarker Research and Evaluation for Clinical Implementation and Supporting Systems Enhancement BRECISE · 101194784 | HORIZON | €13,615,935 | €323,610 | Details |
Verification and validation of a biomarker panel that identifies individuals at high risk to develop Crohn’s disease allowing INTERCEPTION of full-blown disease development INTERCEPT · 101194780 | HORIZON | €15,179,208 | €819,750 | Details |